Technology News and Research

RSS

Advanced Biohealing announces growth strategy to expand its product line

Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced a strategic growth plan designed to continue the transformation of this former start-up into the leading international regenerative medicine company.

24 Sep 2009

Lab-on-a-chip performs 1,000 chemical reactions at once

Flasks, beakers, and hot plates may soon be a thing of the past in medicinal chemistry labs. Instead of handling a few experiments on a benchtop, scientists may simply pop a microchip into a computer and instantly run thousands of chemical reactions, with results literally shrinking the lab down to the size of a thumbnail.

From Siemens Healthineers 23 Sep 2009

Nanodiamonds advance anticancer gene therapy

Gene therapy holds promise in the treatment of cancer as well as a large number of other diseases. However, developing a scalable system for delivering genes to cells both efficiently and safely has been challenging. Now, two teams of researchers have developed versatile nanotechnology-enabled platforms that could get therapeutic genes safely and efficiently into cancer cells.

23 Sep 2009

Titanium dioxide nanoparticles catalyze brain tumor death

Scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory and the University of Chicago Medical Center's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to antibodies.

23 Sep 2009

Magnetic nanoworms and nanocrystals deliver siRNA to tumors

Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials.

23 Sep 2009

Morphotek receives NIAID grant to develop human mAb therapies against staphylococcal-derived pathogens

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced today that it was awarded $843,289 in funding from the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to support the development of human monoclonal antibody (mAb) therapies against staphylococcal-derived toxin(s).

23 Sep 2009

ImmunoCellular Therapeutics completes humanization of its ICT-37 and ICT-109 antibody candidates

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has completed humanization of ICT-37 and ICT-109.

23 Sep 2009

Aspect and Bruker BioSpin collaborate to develop a new high performance desktop preclinical MRI system

At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Aspect Magnet Technologies and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a Memorandum of Understanding (MoU) for the development of a high performance desktop preclinical MRI system.

23 Sep 2009

Philips and Bruker sign MOU to develop new imaging technology

At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Bruker BioSpin, a division of Bruker Corporation, today announced that they have signed a memorandum of understanding (MOU) for the development of Magnetic Particle Imaging (MPI) scanners, a new imaging technology, for the preclinical market.

From Philips Healthcare 23 Sep 2009

NeuroTherm receives US patent for RF generator

NeuroTherm is pleased to be recognized by the United States Patent Office as the first company worldwide to develop and release a multiple output radiofrequency generator used in the treatment of chronic pain, ref. US Patent No. 7,574,257.

23 Sep 2009

Eldorado and WellDyneRx collaborate to create and market integrated claims processing software

Eldorado Computing, Inc. (ELDORADO), a leading provider of health benefit and claims management platforms, and WellDyneRx Inc., a national pharmacy benefits management (PBM) company, announced today that they are collaborating to create and market integrated claims processing software and PBM services to payers.

23 Sep 2009

Stay Fresh textiles technology from Quick-Med

Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today the development of a proprietary Stay Fresh™ technology and that the Company is seeking partners to commercialize this revolutionary new technology in key segments of the textile market.

23 Sep 2009

ART's new generation Optix MX3 optical molecular imaging system unveiled

ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today unveiled a new generation of its optical molecular imaging system, called Optix® MX3, at the Industry Workshop opening event of the World Molecular Imaging Congress.

23 Sep 2009

FDA accepts Sangamo's IND for repeat-dosing in Phase 1 clinical trial of SB-728-T ZFN-based therapeutic

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.

23 Sep 2009

ID Analytics' risk management solutions available on U.S. GSA Schedule

ID Analytics, Inc., the leader in on-demand identity intelligence, announced today its risk management solutions are now available on its' U.S. General Services Administration (GSA) Schedule.

23 Sep 2009

GE Healthcare creates a digital wall to commemorate the tenth anniversary of digital mammography

In addition to being Breast Cancer Awareness Month, this October is the tenth anniversary of digital mammography, a technology introduced by GE Healthcare (NYSE:GE) in 1999. Similar to digital photography, digital mammography replaces the film used in traditional mammography with digital files viewed and stored on computers.

23 Sep 2009

KARL STORZ receives LEED Silver certification

KARL STORZ Endoscopy-America, Inc., a leader in diagnostic and operative minimally invasive endoscopic technology, is proud to announce that it has been awarded LEED® (Leadership in Energy and Environmental Design) Silver certification from the U.S. Green Building Council (USGBC) for the company’s North American Headquarters.

23 Sep 2009

Livingston Securities announces the agenda for the 2nd Annual Livingston Healthcare Summit.

Today, Scott Livingston, CEO and Founder of Livingston Securities (www.livingstonsecurities.com) announced the agenda for the 2nd Annual Livingston Healthcare and Life Science Stakeholders Summit.

23 Sep 2009

Safeguard Scientifics sells additional 2.4 million shares of its position in Clarient

Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that it has sold an additional 2.4 million shares of its position in Clarient, Inc. (Nasdaq: CLRT) through a Clarient shelf registration on Form S-3 that was declared effective by the Securities and Exchange Commission on August 20, 2009.

23 Sep 2009

The Freeplay Foundation's Lifeline radio and Lifelight programs to benefit poor women in Rwanda

The Freeplay Foundation announced today that it has been chosen as a featured organization at this week's meeting of the Clinton Global Initiative. The Foundation has pledged its intent to integrate the award-winning Freeplay Lifeline radio and new clean energy Lifelight into a program benefiting 20,000 extremely poor women and girls across Rwanda.

23 Sep 2009

Technology News and Research

Advanced Biohealing announces growth strategy to expand its product line

Lab-on-a-chip performs 1,000 chemical reactions at once

Nanodiamonds advance anticancer gene therapy

Titanium dioxide nanoparticles catalyze brain tumor death

Magnetic nanoworms and nanocrystals deliver siRNA to tumors

Morphotek receives NIAID grant to develop human mAb therapies against staphylococcal-derived pathogens

ImmunoCellular Therapeutics completes humanization of its ICT-37 and ICT-109 antibody candidates

Aspect and Bruker BioSpin collaborate to develop a new high performance desktop preclinical MRI system

Philips and Bruker sign MOU to develop new imaging technology

NeuroTherm receives US patent for RF generator

Eldorado and WellDyneRx collaborate to create and market integrated claims processing software

Stay Fresh textiles technology from Quick-Med

ART's new generation Optix MX3 optical molecular imaging system unveiled

FDA accepts Sangamo's IND for repeat-dosing in Phase 1 clinical trial of SB-728-T ZFN-based therapeutic

ID Analytics' risk management solutions available on U.S. GSA Schedule

GE Healthcare creates a digital wall to commemorate the tenth anniversary of digital mammography

KARL STORZ receives LEED Silver certification

Livingston Securities announces the agenda for the 2nd Annual Livingston Healthcare Summit.

Safeguard Scientifics sells additional 2.4 million shares of its position in Clarient

The Freeplay Foundation's Lifeline radio and Lifelight programs to benefit poor women in Rwanda

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News